[{"p_text": "COVID-19 can be serious and life-threatening. But in many cases, particularly if someone is vaccinated, the disease is mild. While there is a real risk of\u00a0long COVID\u00a0\u2014 lingering or new symptoms after infection with the coronavirus, which can sometimes be debilitating \u2014 most research suggests people who recover do just fine.", "hrefs": ["https://perma.cc/QY7V-4VZX", "https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html"]}, {"p_text": "Studies show that most people who have been infected with the coronavirus, or SARS-CoV-2, are well-protected against severe disease if infected again, with subsequent or prior vaccination offering even more protection.", "hrefs": ["https://perma.cc/QM3X-YDR7", "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02465-5/fulltext", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00801-5/fulltext"]}, {"p_text": "Yet, as Slate has written, certain corners of the internet have\u00a0misleadingly\u00a0claimed\u00a0that COVID-19 causes widespread immune dysfunction or immunosuppression that is leaving the entire population susceptible to\u00a0all\u00a0sorts\u00a0of subsequent infections. In some cases, COVID-19 has\u00a0incorrectly been likened\u00a0to HIV/AIDS.", "hrefs": ["https://slate.com/technology/2023/01/immunity-covid-research-airborne-aids-debunk.html", "https://slate.com/technology/2022/07/covid-reinfection-omicron-wave-forever-plague.html", "https://perma.cc/EWF6-G6TM", "https://archive.ph/TtrLR"]}, {"p_text": "The latest versions of these\u00a0scaremongering\u00a0claims\u00a0cite a recent paper from a lab at Stanford University and an accompanying\u00a0press release\u00a0from the National Institutes of Health.", "hrefs": ["https://archive.is/vnWGu", "https://archive.is/zG4wT", "https://www.nih.gov/news-events/news-releases/sars-cov-2-infection-weakens-immune-cell-response-vaccination"]}, {"p_text": "\u201cNew study (but not news to anyone paying attention) finds that COVID can damage the immune system in similar ways as HIV or Hepatitis,\u201d one Twitter user\u00a0wrote.", "hrefs": ["https://perma.cc/TK8D-2WHH"]}, {"p_text": "\u201cWhat more do you want?\u201d another Twitter user\u00a0asked, sharing a screenshot from the press release. He continued: \u201chow many times does it need to be shown? that\u2019s the third study I\u2019ve published TODAY showing this HIV like immune deficiency.\u201d", "hrefs": ["https://perma.cc/69G5-WJU9"]}, {"p_text": "Both the paper,\u00a0published\u00a0in the journal Immunity, and the news release do include statements that could seem to support some of these interpretations. But the senior author told us the comparison to other viruses had been misunderstood, and the immune defect his group identified is not so severe as an immunodeficiency.", "hrefs": ["https://www.cell.com/immunity/fulltext/S1074-7613(23)00125-5"]}, {"p_text": "\u201c[T]here\u2019s really no evidence \u2026 that SARS-CoV-2 infection causes long term immune damage similar to HIV or HCV,\u201d\u00a0E. John Wherry, an immunologist at the University of Pennsylvania, told us in an email, referring to hepatitis C virus. \u201cThese claims are not based on solid data \u2013 either rigorous immunological assessment or real world manifestation of increases in other infections or diseases related to immune suppression.\u201d", "hrefs": ["https://www.med.upenn.edu/wherrylab/"]}, {"p_text": "The Immunity\u00a0paper, which was published on March 15 and authored by\u00a0Mark M. Davis\u2019 lab at Stanford, analyzed T cells found in the blood of people after COVID-19 vaccination, SARS-CoV-2 infection or both.", "hrefs": ["https://www.cell.com/immunity/fulltext/S1074-7613(23)00125-5#%20", "https://profiles.stanford.edu/mark-davis"]}, {"p_text": "T cells are one arm of the adaptive immune system. One subset, known as CD4 T cells, helps B cells make antibodies and helps coordinate the immune response. Another subset, known as CD8 T cells, kills infected cells to limit the spread of viruses.", "hrefs": ["https://www.ncbi.nlm.nih.gov/books/NBK279396/"]}, {"p_text": "In their discussion, the authors made a comparison to infection with HIV and hepatitis C virus, noting that reduced CD8 T cell function has been\u00a0observed\u00a0in patients as long as a year after those viruses were either fully or nearly eliminated. This comparison was then highlighted in an NIH press release, which people on social media then quoted to lend credence to the false idea that COVID-19 is HIV-like.", "hrefs": ["https://www.pnas.org/doi/full/10.1073/pnas.2022928118"]}, {"p_text": "But the authors\u2019 comparison is specific to a particular phenomenon with those viruses and their effects on CD8 T cells after total or near-total viral clearance. It doesn\u2019t mean COVID-19 causes an immunodeficiency on par with HIV, which permanently\u00a0damages the immune system\u00a0by killing off a person\u2019s CD4 T cells.", "hrefs": ["https://hivinfo.nih.gov/understanding-hiv/fact-sheets/hiv-and-aids-basics"]}, {"p_text": "As\u00a0Danny Altmann, a professor of immunology at Imperial College London, told us, the \u201cimmune effects of Covid are nothing like HIV at all.\u201d", "hrefs": ["https://www.imperial.ac.uk/people/d.altmann"]}, {"p_text": "\u201cThe scale of the defect in HIV and HCV is so much greater that I think anything that\u2019s being reported here \u2014 even if we take it at face value \u2014 that I think that was a \u2026 risky analogy to make,\u201d\u00a0Paul G. Thomas, an immunologist at St. Jude Children\u2019s Research Hospital, said in a phone interview. \u201cI think that\u2019s caused a lot of alarm and a lot of frantic press speculation that\u2019s really not warranted.\u201d", "hrefs": ["https://www.stjude.org/directory/t/paul-thomas.html"]}, {"p_text": "Thomas, who\u00a0published\u00a0a paper in Nature Immunology in April 2022 that did not find any CD8 T cell defects, emphasized that the Stanford paper is just one of many other studies from groups using a variety of techniques that have come to opposite conclusions.", "hrefs": ["https://www.nature.com/articles/s41590-022-01184-4"]}, {"p_text": "There are exceptions when there are problems with the immune system. People who have had very severe COVID-19 do sometimes have very low counts of T and B cells, for example. And with long COVID, there could be other immune problems, although those still wouldn\u2019t be considered a full immunodeficiency.", "hrefs": ["https://doi.org/10.1177/20587392211036825"]}, {"p_text": "Other scientists weren\u2019t as critical of the Immunity paper. Altmann, of Imperial College London, said in an email that the study was from \u201ca superb and reliable lab, and their answers stand.\u201d He added that the work is \u201csomewhat similar\u201d to another paper\u00a0published\u00a0in January 2022 in Nature Immunology, which identified immune system differences the authors termed \u201cimmunological dysfunction\u201d eight months after mild-to-moderate infection.", "hrefs": ["https://www.nature.com/articles/s41590-021-01113-x"]}, {"p_text": "However, Altmann noted that other \u201cequally excellent research,\u201d\u00a0published\u00a0in Nature in January, came to the opposite conclusion, finding that males who had recovered from mild COVID-19 actually had better responses to a flu vaccine than those who never had COVID-19.", "hrefs": ["https://www.nature.com/articles/s41586-022-05670-5"]}, {"p_text": "Editor\u2019s note: SciCheck\u2019s articles providing accurate health information and correcting health misinformation are made possible by a grant from the Robert Wood Johnson Foundation. The foundation has no control over FactCheck.org\u2019s editorial decisions, and the views expressed in our articles do not necessarily reflect the views of the foundation.", "hrefs": ["https://www.factcheck.org/2021/04/scicheck-and-our-committment-to-transparency/"]}]